Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 3, Number 6, June 2005

Favourites:
ADD

Free Content The discovery and characterization of platelet GPIb
pp. 1125-1132(8)
Authors: SOLUM, N. O.; CLEMETSON, K. J.

Favourites:
ADD

Free Content The effect of birth weight on clottable and intact fibrinogen levels: a twin study
pp. 1143-1148(6)
Authors: TUYA, C.; MUTCH, W. J.; BROOM, I.; MCNEILL, G.

Favourites:
ADD

Free Content Superficial thrombophlebitis of the legs: still a lot to learn
pp. 1149-1151(3)
Authors: DECOUSUS, H.; LEIZOROVICZ, A.

Favourites:
ADD

Free Content The presence of IgG antibodies against β2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant
pp. 1160-1165(6)
Authors: ZOGHLAMI-RINTELEN, C.; VORMITTAG, R.; SAILER, T.; LEHR, S.; QUEHENBERGER, P.; RUMPOLD, H.; MALE, C.; PABINGER, I.

Favourites:
ADD

Free Content Microparticles in type 2 diabetes mellitus
pp. 1166-1167(2)
Authors: DAVÌ, G.; FERRONI, P.

Favourites:
ADD

Free Content Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes
pp. 1168-1171(4)
Authors: SOMMEIJER, D. W.; JOOP, K.; LEYTE, A.; REITSMA, P. H.; CATE, H.TEN

Favourites:
ADD

Free Content The adipocyte speaks: are we listening?
pp. 1172-1173(2)
Author: GRANT, P. J.

Favourites:
ADD

Free Content On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice
pp. 1174-1179(6)
Authors: LIJNEN, H. R.; ALESSI, M-C; VAN HOEF, B.; COLLEN, D.; JUHAN-VAGUE, I.

Favourites:
ADD

Free Content Pharmacokinetics and pharmacodynamics of BB-10153 , a thrombin-activatable plasminogen, in healthy volunteers
pp. 1180-1186(7)
Authors: CURTIS, L. D.; BROWN, A.; COMER, M. B.; SENIOR, J. M.; WARRINGTON, S.; DAWSON, K. M.

Favourites:
ADD

Free Content Prevention of venous thromboembolism after acute ischemic stroke
pp. 1187-1194(8)
Authors: KAMPHUISEN, P. W.; AGNELLI, G.; SEBASTIANELLI, M.

Favourites:
ADD

Free Content Gene therapy for hemophilia: an imperative to succeed
pp. 1195-1205(11)
Authors: HOUGH, C.; LILLICRAP, D.

Favourites:
ADD

Free Content Genetic factors contribute to bleeding after cardiac surgery
pp. 1206-1212(7)
Authors: WELSBY, I. J.; PODGOREANU, M. V.; PHILLIPS-BUTE, B.; MATHEW, J. P.; SMITH, P. K.; NEWMAN, M. F.; SCHWINN, D. A.; STAFFORD-SMITH, M.

Favourites:
ADD

Free Content Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke
pp. 1213-1217(5)
Authors: SLOOTER, A. J. C.; ROSENDAAL, F. R.; TANIS, B. C.; KEMMEREN, J. M.; GRAAF, Y.; ALGRA, A.

Favourites:
ADD

Free Content Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome
pp. 1218-1223(6)
Authors: PACIARONI, M.; AGNELLI, G.; CASO, V.; VENTI, M.; MILIA, P.; SILVESTRELLI, G.; PARNETTI, L.; BIAGINI, S.

Favourites:
ADD
Favourites:
ADD

Free Content A prospective study of antibodies to β2-glycoprotein I and prothrombin, and risk of thrombosis
pp. 1231-1238(8)
Authors: FORASTIERO, R.; MARTINUZZO, M.; POMBO, G.; PUENTE, D.; ROSSI, A.; CELEBRIN, L.; BONACCORSO, S.; AVERSA, L.

Favourites:
ADD

Free Content D-Dimer test in cancer patients with suspected acute pulmonary embolism
pp. 1239-1242(4)
Authors: DI NISIO, M.; SOHNE, M.; KAMPHUISEN, P. W.; BÜLLER, H. R.

Favourites:
ADD

Free Content Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation
pp. 1243-1249(7)
Authors: REGNAULT, V.; BOEHLEN, F.; OZSAHIN, H.; WAHL, D.; DE GROOT, P. G.; LECOMPTE, T.; DE MOERLOOSE, P.

Favourites:
ADD

Free Content Interspecies exchange mutagenesis of the first epidermal growth factor-like domain of human factor VII
pp. 1250-1256(7)
Authors: WILLIAMSON, V.; PYKE, A.; SRIDHARA, S.; KELLEY, R. F.; BLAJCHMAN, M. A.; CLARKE, B. J.

Favourites:
ADD

Free Content The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor
pp. 1257-1265(9)
Authors: BOVENSCHEN, N.; RIJKEN, D. C.; HAVEKES, L. M.; VLIJMEN, B. J. M.; MERTENS, K.

Favourites:
ADD

Free Content The expression of prion protein (PrPC) in the megakaryocyte lineage
pp. 1266-1273(8)
Authors: STARKE, R.; HARRISON, P.; MACKIE, I.; WANG, G.; ERUSALIMSKY, J. D.; GALE, R.; MASSÉ, J-M.; CRAMER, E.; PIZZEY, A.; BIGGERSTAFF, J.; MACHIN, S.

Favourites:
ADD

Free Content A tripeptide mimetic of von Willebrand factor residues 981–983 enhances platelet adhesion to fibrinogen by signaling through integrin βIIbβ3
pp. 1274-1283(10)
Authors: LITJENS, P. E. M. H.; WILLIGEN, G.; WEETERINGS, C.; IJSSELDIJK, M. J. W.; LIER, M.; KOIVUNEN, E.; GAHMBERG, C. G.; AKKERMAN, J. W. N.

Favourites:
ADD

Free Content A new functional assay of thrombin activatable fibrinolysis inhibitor
pp. 1284-1292(9)
Authors: GUIMARÃES, A. H. C.; BERTINA, R. M.; RIJKEN, D. C.

Favourites:
ADD

Free Content Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor
pp. 1293-1300(8)
Authors: MARX, P. F.; HAVIK, S. R.; BOUMA, B. N.; MEIJERS, J. C. M.

Favourites:
ADD

Free Content Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation
pp. 1301-1308(8)
Authors: JY, W.; JIMENEZ, J. J.; MAURO, L. M.; HORSTMAN, L. L.; CHENG, P.; AHN, E. R.; BIDOT, C. J.; AHN, Y. S.

Favourites:
ADD

Free Content Aspirin resistance: position paper of the Working Group on Aspirin Resistance
pp. 1309-1311(3)
Authors: MICHELSON, A. D.; CATTANEO, M.; EIKELBOOM, J. W.; GURBEL, P.; KOTTKE-MARCHANT, K.; KUNICKI, T. J.; PULCINELLI, F. M.; CERLETTI, C.; RAO, A. K.

Favourites:
ADD

Free Content Gene therapy for hemophilia?
pp. 1312-1312(1)
Authors: WHITE, G. C.; ROBERTS, H. R.

Favourites:
ADD

Free Content Gene therapy for hemophilia?
pp. 1313-1313(1)
Author: SRIVASTAVA, A.

Favourites:
ADD

Free Content Gene therapy for hemophilia?
pp. 1314-1314(1)
Author: TUDDENHAM, E. G. D.

Favourites:
ADD

Free Content Gene therapy for hemophilia?
pp. 1315-1316(2)
Author: DIMICHELE, D.

Favourites:
ADD

Free Content Gene therapy for hemophilia?
pp. 1316-1317(2)
Author: HOOTS, W. K.

Favourites:
ADD

Free Content Gene therapy for hemophilia?
pp. 1317-1319(3)
Author: BRETTLER, D. B.

Favourites:
ADD

Free Content Future perspective for the treatment of hemophilia A
pp. 1320-1321(2)
Author: LAURIAN, Y.

Favourites:
ADD

Free Content Relatively high frequency of VWD types 3 and 2 in a cohort of Indian patients: the role of multimeric analysis
pp. 1321-1323(3)
Authors: GUPTA, P. K.; AHMED, R. P. H.; SAZAWAL, S.; CHOUDHRY, V. P.; SAXENA, R.

Favourites:
ADD

Free Content Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosis
pp. 1323-1324(2)
Authors: EROGLU, A.; KURTMAN, C.; ULU, A.; ÇAM, R.; AKAR, N.

Favourites:
ADD

Free Content A case of cyclosporine-induced dural sinus thrombosis
pp. 1327-1328(2)
Authors: AL-SHEKHLEE, A.; OGHLAKIAN, G.; KATIRJI, B.

Favourites:
ADD

Free Content More on: asymptomatic thrombophilia—a family affair
pp. 1329-1330(2)
Authors: PERNOD, G.; JOUK, P. S.; BOSSON, J. L.; CARPENTIER, P. H.; POLACK, B.

Favourites:
ADD

Free Content Talking about…
pp. 1331-1334(4)
Authors: BRUTTOMESSO, G.; MIGLINO, N.

Favourites:
ADD

Free Content Announcements
pp. 1335-1335(1)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more